NL-OMON55871
Completed
Phase 2
A prospective follow-up Intervention Study: Detection of Early Esophageal Cancer by Near-Infrared Fluorescence molecular Endoscopy using Bevacizumab-800CW - Detection of Early Esophageal Cancer by NIR-FME. ESCEND
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversitair Medisch Centrum Groningen
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- Suspicion or diagnosed LGD, HGD or superficial EAC and planned diagnostic
- •and/or therapeutic \- endoscopy.
- •\- Age: 18 years or older.
- •\- Written informed consent.
Exclusion Criteria
- •\- Patients younger than 18 years old
- •\- Submucosal and invasive EAC; EAC with TNM\-classification other than T1\.
- •\- Radiation therapy for esophageal cancer
- •\- Immunoglobulin allergy
- •\- Chemotherapy, immunotherapy or surgery 28 days before administration of the
- •\- Prior Bevacizumab or Cetuximab treatment
- •\- Patients using anti\-epileptic drugs (only exclusion criterium for the ICG
- •\- Non\-adjustable hypertension
- •\- Medical or psychiatric conditions that compromise the patient\*s ability to
- •give informed consent.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
tility of Homoeopathy in MigraineHealth Condition 1: G431- Migraine with auraHealth Condition 2: G430- Migraine without auraHealth Condition 3: G439- Migraine, unspecifiedCTRI/2024/05/067106Rajkot Homoeopathic Medical College
Not Yet Recruiting
N/A
To study the effectiveness of individualized homoeopathic medicine in cases of sciatica.CTRI/2024/05/067967Sainath Hospital
Active, Not Recruiting
Phase 4
Study to Determine the Effectiveness of ORSL�® variants as an Adjuvant to help restore Oral Fluid, Electrolytes and Energy (FEE) Along With Standard of Care Medication Treatment inRecovery for Subjects With Fever And/Or General Weakness in Out-Patient Setting Among the Indian PopulatioCTRI/2021/10/037363Johnson and Johnson Pte Limited
Active, Not Recruiting
N/A
APPRECIATEJPRN-jRCTs031210665Kawahito Yutaka55
Recruiting
Phase 2
Efficacy of Intraoperative Fluorescence Diagnosis in Meningioma surgerymeningiomaMeningiomaJPRN-jRCTs031210158Masahide Matsuda22